Further characterization of human α2-adrenoceptor subtypes: [3H]RX821002 binding and definition of additional selective drugs
- 24 January 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 252 (1), 43-49
- https://doi.org/10.1016/0014-2999(94)90573-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Differential expression of two α2-adrenergic receptor subtype mRNAs in human tissuesMolecular Brain Research, 1992
- Regional Distribution of α2A‐and α2B‐Adrenoceptor Subtypes in Postmortem Human BrainJournal of Neurochemistry, 1992
- Identification of human platelet a2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxanBritish Journal of Pharmacology, 1990
- Assessment of imiloxan as a selective α2B‐adrenoceptor antagonistBritish Journal of Pharmacology, 1990
- [3H]RX821002: a new tool for the identification of α2A-adrenoceptorsEuropean Journal of Pharmacology, 1989
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987
- [71] Use of eukaryotic expression technology in the functional analysis of cloned genesMethods in Enzymology, 1987
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973